CUSIP 03969F109COMRCUSQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
206 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Gilead Sciences, Inc. | 31.42M | $748.85M | 0 | Held |
| 2 | Blackrock, Inc. | 15.00M | $357.40M | +3.19M | Added |
| 3 | Vanguard Group Inc | 7.96M | $189.76M | +1.33M | Added |
| 4 | Suvretta Capital Management, LLC | 5.19M | $123.65M |
| +1.50M |
| Added |
| 5 | Wellington Management Group LLP | 5.18M | $123.55M | +3.92M | Added |
| 6 | State Street Corp | 4.58M | $109.07M | +1.18M | Added |
| 7 | Woodline Partners LP | 3.77M | $89.83M | +104 | Added |
| 8 | Marshall Wace, LLP | 3.39M | $80.73M | +3.39M | New |
| 9 | Point72 Asset Management, L.P. | 3.28M | $78.16M | −1.05M | Reduced |
| 10 | Siren, L.L.C. | 3.01M | $71.66M | +95.0K | Added |
See every fund holding Arcus Biosciences Inc, with full quarter-over-quarter share changes.
Unlock all holders